Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27. (Q45940824)

18 December 2017

title

Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27. (English)

1 reference

18 December 2017

Timothy D Warner

8

0 references

author name string

Kin Chung Leung

1

1 reference

18 December 2017

Michael K Y Hsin

2

1 reference

18 December 2017

Joey S Y Chan

3

1 reference

18 December 2017

Johnson H Y Yip

4

1 reference

18 December 2017

Mingyue Li

5

1 reference

18 December 2017

Billy C S Leung

6

1 reference

18 December 2017

Tony S K Mok

7

1 reference

18 December 2017

Malcolm J Underwood

9

1 reference

18 December 2017

George G Chen

10

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

18 December 2017

Experimental Cell Research

published in

1 reference

18 December 2017

volume

315

1 reference

18 December 2017

issue

17

1 reference

18 December 2017

page(s)

2974-2981

1 reference

18 December 2017

Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Cyclo-oxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Up-regulation of ICH-1L protein by thromboxane A2 antagonists enhances cisplatin-induced apoptosis in non-small-cell lung-cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Downregulation of the KIP family members p27KIP1and p57KIP2by SKP2 and the role of methylation in p57KIP2inactivation in nonsmall cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Adenovirus expressing p27(Kip1) induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Involvement of p27(kip1) in ceramide-mediated apoptosis in HL-60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Effect of adenovirus-mediated p27 gene expression on the proliferation and apoptosis of HL-60 and Raji cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Arachidonic acid metabolites produced by platelet-depleted human blood monocytes: a possible role in thrombogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.06.025

10.1016/J.YEXCR.2009.06.025

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19576211

1 reference

18 December 2017